Recommendations & Conclusions
11 items
2
Recommendation
Third Report - Pharmacy
Deferred
We recommend that the Community Pharmacy Contractual Framework (CPCF) is completely overhauled, in close consultation with the community pharmacy sector. Any new framework must: a) close the gap in funding that community pharmacy has experienced over the course of the current CPCF; b) focus on reducing complexity and ensure pharmacy …
Read more
We recommend that the Community Pharmacy Contractual Framework (CPCF) is completely overhauled, in close consultation with the community pharmacy sector. Any new framework must: a) close the gap in funding that community pharmacy has experienced over the course of the current CPCF; b) focus on reducing complexity and ensure pharmacy owners can clearly understand and predict their cash flow, including de-risking the purchasing price of medicines; c) ensure funding is explicitly available for both dispensing services and clinical services, to avoid the current situation where one activity pays for another, to the detriment of both d) include the capacity for flexibility in the event of increased demand, greater activity or inflationary pressures, for example through indexation. (Paragraph 20) Medicine Shortages
Show less
Government response AI summary
The government's response focused on Serious Shortage Protocols (SSPs) as a tool to manage medicine shortages, explaining their use and stating that the policy will continue to be kept under review. It did not address the recommendation to completely overhaul the Community Pharmacy Contractual Framework.
Read full response →
Department of Health and Social Care
5
Recommendation
Third Report - Pharmacy
Deferred
We recommend that the Government reviews the effectiveness of Serious Shortage Protocols, with a focus on their timing and their administrative burden. (Paragraph 49) 44 Pharmacy
Government response AI summary
The government discusses the role of National Patient Safety Alerts and Medicine Supply Notifications in managing shortages, but does not address the specific recommendation to review the effectiveness, timing, or administrative burden of Serious Shortage Protocols (SSPs).
Read full response →
Department of Health and Social Care
7
Recommendation
Third Report - Pharmacy
Deferred
We believe that allowing generic substitution would be an important way of reducing the need for patients to return to their GP for out-of-stock medication. We further recommend the introduction of generic substitution, which should follow a government consultation focusing on how best this policy could be implemented to ensure …
Read more
We believe that allowing generic substitution would be an important way of reducing the need for patients to return to their GP for out-of-stock medication. We further recommend the introduction of generic substitution, which should follow a government consultation focusing on how best this policy could be implemented to ensure patient safety and avoid the potential for unintended impacts on the supply chain.
Show less
Government response AI summary
The government responds by outlining its commitment to expanding the role of pharmacists and introducing prescribing services, but does not address the specific recommendation to introduce generic substitution or to consult on its implementation.
Read full response →
Department of Health and Social Care
8
Recommendation
Third Report - Pharmacy
Deferred
In their response to this report, the Government should set out what impact it believes National Patient Safety Alerts have on private prescribing and what scrutiny and enforcement measures are in place to ensure private prescribers adhere to these alerts.
Read more
In their response to this report, the Government should set out what impact it believes National Patient Safety Alerts have on private prescribing and what scrutiny and enforcement measures are in place to ensure private prescribers adhere to these alerts.
Show less
Government response AI summary
The government acknowledges the point but then discusses the new HIV Action Plan for 2025-30 and PrEP access, mentioning pilot studies for PrEP delivery, without addressing the impact of National Patient Safety Alerts on private prescribing or their enforcement.
Read full response →
Department of Health and Social Care
9
Conclusion
Third Report - Pharmacy
Deferred
The global supply chain for medicines is complex, with a range of different actors involved in getting medicines from the raw materials to the manufacturer to the patient. The Government needs a clearer understanding and overview of the whole process, and the risks at each stage. If the Government already …
Read more
The global supply chain for medicines is complex, with a range of different actors involved in getting medicines from the raw materials to the manufacturer to the patient. The Government needs a clearer understanding and overview of the whole process, and the risks at each stage. If the Government already has that clarity, that should be communicated to Parliament. Only then can weaknesses in the chain, their causes, and how to tackle them be truly established so that the Government can get on top of this growing issue and provide the necessary solutions.
Show less
Government response AI summary
The government discusses its commitment to expanding pharmacy services and promoting the Pharmacy First service, but does not address the recommendation about gaining a clearer understanding of the entire medicines supply chain and communicating it to Parliament.
Read full response →
Department of Health and Social Care
10
Recommendation
Third Report - Pharmacy
Deferred
The Government should commission an independent review of the medicines supply chain. Given the impact that shortages are having, this should be commissioned as soon as possible and completed within 6 months of starting. The review should assess, and suggest ways of improving, the resilience of the supply chain, the …
Read more
The Government should commission an independent review of the medicines supply chain. Given the impact that shortages are having, this should be commissioned as soon as possible and completed within 6 months of starting. The review should assess, and suggest ways of improving, the resilience of the supply chain, the performance and role of the MHRA and the impact of prices paid for medicines and community pharmacy reimbursement mechanisms. We recommend a particular focus on the availability and use of generic medicines, though the review should not be limited to these. (Paragraph 64) Extending pharmacy services
Show less
Government response AI summary
The government discusses past and present pharmacy funding mechanisms, including the phased-out establishment payment and the Pharmacy First monthly payment, without addressing the recommendation to commission an independent review of the medicines supply chain.
Read full response →
Department of Health and Social Care
11
Conclusion
Third Report - Pharmacy
Deferred
We have been encouraged to hear the enthusiasm within the pharmacy profession to deliver more patient facing care. However, the undoubted potential for pharmacy to improve access to health care, crucially including immunisations, and reduce pressure on general practice and other areas of the health system can only be realised …
Read more
We have been encouraged to hear the enthusiasm within the pharmacy profession to deliver more patient facing care. However, the undoubted potential for pharmacy to improve access to health care, crucially including immunisations, and reduce pressure on general practice and other areas of the health system can only be realised with the right support and the right investment of public funding.
Show less
Government response AI summary
The government details the charging structure for Pharmacy First consultations and prescription medications, and references a 2018 report on over-the-counter medication, instead of addressing the need for increased public funding and support for expanded pharmacy services.
Read full response →
Department of Health and Social Care
15
Recommendation
Third Report - Pharmacy
Deferred
While hub and spoke arrangements may be beneficial to some pharmacies, we do not believe this is a ‘silver bullet’ in terms of efficiencies. We urge the Government not to assume that hub and spoke alone will deliver the extra capacity pharmacists clearly need to deliver clinical services. We note …
Read more
While hub and spoke arrangements may be beneficial to some pharmacies, we do not believe this is a ‘silver bullet’ in terms of efficiencies. We urge the Government not to assume that hub and spoke alone will deliver the extra capacity pharmacists clearly need to deliver clinical services. We note the Government’s response to their consultation and intention to proceed with plans to allow hub and spoke systems to be set up across different legal entities, but caution against encouraging, or even mandating, more widespread implementation.
Show less
Government response AI summary
The government deflected the recommendation about hub and spoke arrangements by discussing the eligibility of MPharm students for the Learning Support Fund and exploring consistent policy for funding their travel and accommodation costs.
Read full response →
Department of Health and Social Care
16
Conclusion
Third Report - Pharmacy
Deferred
Public concerns about being referred back to the GP if they use community pharmacy to access healthcare should ring alarm bells for the Government. It is encouraging that this does not seem to be the experience within Pharmacy First, but we know that medicine shortages are driving people back to …
Read more
Public concerns about being referred back to the GP if they use community pharmacy to access healthcare should ring alarm bells for the Government. It is encouraging that this does not seem to be the experience within Pharmacy First, but we know that medicine shortages are driving people back to their GPs. We are concerned that this reinforces the public concerns.
Show less
Government response AI summary
The government stated that funding for the Additional Role Reimbursement Scheme (ARRS) is under review as part of the 2025/26 GP contract arrangements, with final details to be published after the consultation concludes, rather than directly addressing public concerns about GP referrals or medicine shortages.
Read full response →
Department of Health and Social Care
18
Conclusion
Third Report - Pharmacy
Deferred
Community pharmacies offering clinical services must have private, comfortable spaces in which to see patients. We acknowledge the minister’s comments around pharmacies being private businesses, but they are ultimately expected to provide NHS services. As the expanding availability of clinical services in pharmacy settings is encouraged, we believe a more …
Read more
Community pharmacies offering clinical services must have private, comfortable spaces in which to see patients. We acknowledge the minister’s comments around pharmacies being private businesses, but they are ultimately expected to provide NHS services. As the expanding availability of clinical services in pharmacy settings is encouraged, we believe a more balanced approach is needed to support smaller, particularly independent, pharmacies to keep up with larger ones and have the resources to create the appropriate conditions in which to provide the new services that the Government and the public want to see. (Paragraph 105) 46 Pharmacy
Show less
Government response AI summary
The government deflected the recommendation regarding private consultation spaces by focusing on the refreshed Long Term Workforce Plan and workforce development, including supporting pharmacists to become independent prescribers and piloting an Independent Prescriber Pathfinder Programme.
Read full response →
Department of Health and Social Care
19
Recommendation
Third Report - Pharmacy
Deferred
We recommend the creation of a new “Establishment Payment” to be paid to eligible community pharmacies to support the development of consultation spaces for patients. This funding should be targeted at pharmacies that are the most reliant on NHS work as their main source of income and could be linked …
Read more
We recommend the creation of a new “Establishment Payment” to be paid to eligible community pharmacies to support the development of consultation spaces for patients. This funding should be targeted at pharmacies that are the most reliant on NHS work as their main source of income and could be linked to a commitment to provide an agreed level of NHS service.
Show less
Government response AI summary
The government deflected the recommendation for a new 'Establishment Payment' to support consultation spaces by discussing pharmacy workforce integration within Integrated Care Boards and the ongoing exploration of how to best utilise pharmacy skills for future services.
Read full response →
Department of Health and Social Care